Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Total Current Assets
All assets expected to be converted to cash or used up within one year.
Microbot Medical Inc.NASDAQ: MBOT
Total Current Assets · Q1 FY2026 · quarter ended Mar 2026
Total current assets rises 149.6% from a year ago
Total current assets stood at $76.53M at the end of Q1 FY2026, up 149.6% from a year earlier and down 4.1% from the prior quarter. Over 3 fiscal years it compounded at +108.4% a year.
Context
- Total current assets amounted to 98.0% of total assets at the end of Q1 FY2026, down 1.2 pp from a year earlier.
- Total current assets increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current assets keeps rising in the next quarterly balance sheet after a +149.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 79.82M USD
- Year-over-year change
- +1271.7%
- 4-year CAGR
- +49.7%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 79.82M | +1271.7% |
| FY2024 | 2024-12-31 | 5.82M | -26.5% |
| FY2023 | 2023-12-31 | 7.92M | -10.1% |
| FY2022 | 2022-12-31 | 8.81M | -44.5% |
| FY2021 | 2021-12-31 | 15.88M | — |
Total Current Assets vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so total current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +149.6% is the 2nd highest of 10, against a peer median of -34.0%.
- Total current assets amounts to 98.0% of total assets for MBOT, versus a peer median of 61.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $160.15M USD | +248.7% | -11.7% | 71.0% | |
| Mar 2026 | $138.17M USD | -47.4% | -17.5% | 66.0% | |
| Mar 2026 | $76.53M USD | +149.6% | +108.4% | 98.0% | |
| Mar 2026 | $68.15M USD | -48.2% | -5.3% | 25.3% | |
| Mar 2026 | $58.52M USD | -36.9% | +21.8% | 99.4% | |
| Mar 2026 | $31.65M USD | -34.0% | -26.0% | 61.4% | |
| Mar 2026 | CA$31.35M CAD | +24.0% | -19.7% | 99.6% | |
| Mar 2026 | $21.55M USD | +45.1% | -27.8% | 50.9% | |
| Mar 2026 | $13.02M USD | -11.2% | -32.5% | 60.1% | |
| Mar 2026 | CA$2.28M CAD | -47.7% | -49.7% | 15.1% | |
| Peer median (excluding MBOT) | — | -34.0% | -19.7% | 61.4% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.